Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Emis Group Plc    EMIS   GB00B61D1Y04

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Emis Group Plc : Smarter software to make GP prescribing safer

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/05/2012 | 01:41am EST
Friday, 4 May 2012

Smarter software to make GP prescribing safer

A call from the General Medical Council (GMC) for smarter software to help GPs reduce prescribing errors has highlighted EMIS's position as an industry leader in decision support technology.

Many of the issues highlighted in the GMC-commissioned study are already covered by the EMIS Web integrated care system - including sophisticated prescribing alerts that don't overload the GP and direct electronic links with pharmacists, closing the prescribing loop.

GMC chair Professor Peter Rubin said GPs needed to invest in better technology following a GMC-commissioned study that revealed mistakes or omissions in one in 20 prescriptions. The GMC also called for GPs and pharmacists to work together more closely to reduce the risk of errors.

Complex decisions

Dr Shaun O'Hanlon, clinical and development director at EMIS said: "This important study has revealed just how complex prescribing decisions are, and as a former GP, I know that there are times when we need to balance one risk against another - this is often not evident when reviewing the prescription in isolation.

"However, the good news is that the smart software called for by the GMC is already being implemented - an increasing number of GPs and pharmacists using EMIS Web, our integrated record system, have the very latest tools to make prescribing safer.

Avoid 'alert fatigue'

"EMIS Web includes advanced decision support for prescribing, which flags up key drug safety alerts that make GPs stop and think, and even justify their decision, circumventing 'alert fatigue'.

"It also allows GPs to monitor and manage patients on drugs with a low therapeutic index such as Warfarin more safely. Our medication management tool informs GPs when the patient they are seeing or prescribing for is overdue for an INR check - the commonest serious issue mentioned in the report. Integration in EMIS Web of SMS alerting to the patient when monitoring is overdue is another way of improving safety - and involving patients in their own care." 

Linking GPs and pharmacists

He added: "Close links between GPs and local community pharmacists are of course vital to improve prescribing, and the Medicines Manager tool, developed jointly by EMIS and Rx Systems, allows them to communicate with each other electronically about patients' repeat medication and exchange information directly.

"GPs and community pharmacies are already collaborating when making complex prescribing decisions and are realising the benefits in terms of patient safety, compliance and improved care."

Media enquiries: Contact Libby Howard or Ruth Devlin, Judge & Howard,
tel: 0161 212 1611, email . Out-of-hours enquiries to
Libby Howard on 07879 446277.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EMIS GROUP PLC
2016 EMIS : Chief Executive Chris Spencer To Retire By End Of 2017
2016 EMISPHERE TECHNOLOGIES, INC. (LON : EMIS) Files An 8-K Entry into a Material Def..
2016 EMISPHERE TECHNOLOGIES, INC. (LON : EMIS) Files An 8-K Other Events
2016 EMIS : Director Dealing
2016 EMIS GROUP PLC : ex-dividend day for interim dividend
2016 EMIS : GP practice saves up to 40 days a year with online test results for patie..
2016 EMIS : Notification of Transaction of Directors
2016 EMIS : Notification of Major Interest in Shares
2016 EMIS : Profit Down On Costs, But Revenue Rises In First Half
2016 EMIS : Half-year Report
More news
Sector news : Medical Software & Technology Services
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Medical Software & Technology Services
News from SeekingAlpha
2015 NOVO-NORDISK'S ORAL GLP-1 DIABETES T : An Update
Advertisement
Financials ( GBP)
Sales 2016 163 M
EBIT 2016 36,8 M
Net income 2016 25,5 M
Debt 2016 0,27 M
Yield 2016 2,47%
P/E ratio 2016 24,61
P/E ratio 2017 22,22
EV / Sales 2016 3,65x
EV / Sales 2017 3,39x
Capitalization 595 M
More Financials
Chart EMIS GROUP PLC
Duration : Period :
Emis Group Plc Technical Analysis Chart | EMIS | GB00B61D1Y04 | 4-Traders
Full-screen chart
Technical analysis trends EMIS GROUP PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 10,8  GBP
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Christopher Michael Kennedy Spencer Chief Executive Officer & Executive Director
Michael Kevin O'Leary Non-Executive Chairman
Peter Southby Chief Financial Officer & Executive Director
Shaun O’Hanlon Chief Medical Officer
Phil Webb Chief Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EMIS GROUP PLC-2.54%736
VEEVA SYSTEMS INC5.50%5 890
HEALTHEQUITY INC17.70%2 831
ALLSCRIPTS HEALTHCARE ..11.85%2 114
EVOLENT HEALTH INC27.03%1 277
OMNICELL, INC.-0.89%1 227
More Results